{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:20:29Z","timestamp":1789582829641,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["BLJ18J006"],"award-info":[{"award-number":["BLJ18J006"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.arth.2025.04.049","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T02:28:26Z","timestamp":1745634506000},"page":"2575-2585.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Perioperative Use of Bisphosphonate and Implant Survival After Total Joint Arthroplasty"],"prefix":"10.1016","volume":"40","author":[{"given":"Yiyun","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiansheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2025.04.049_bib1","article-title":"Zoledronic acid for periprosthetic bone mineral density changes in patients with osteoporosis after hip arthroplasty-an updated meta-analysis of six randomized controlled trials","volume":"8","author":"Liu","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.arth.2025.04.049_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijsu.2018.02.007","article-title":"Risedronate reduces postoperative bone resorption after cementless total hip arthroplasty: a systematic review and meta-analysis","volume":"52","author":"Wang","year":"2018","journal-title":"Int J Surg"},{"key":"10.1016\/j.arth.2025.04.049_bib3","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00198-018-4488-7","article-title":"Bisphosphonates for the preservation of periprosthetic bone mineral density after total joint arthroplasty: a meta-analysis of 25 randomized controlled trials","volume":"29","author":"Shi","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.arth.2025.04.049_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12891-018-2101-z","article-title":"Effect of bisphosphonates on periprosthetic bone loss after total knee arthroplasty: a meta-analysis of randomized controlled trials","volume":"19","author":"Shi","year":"2018","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.arth.2025.04.049_bib5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijsu.2017.08.559","article-title":"Effect of zoledronic acid on reducing femoral bone mineral density loss following total hip arthroplasty: a meta-analysis from randomized controlled trails","volume":"47","author":"Gao","year":"2017","journal-title":"Int J Surg"},{"key":"10.1016\/j.arth.2025.04.049_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jbiomech.2018.04.041","article-title":"A long-lasting bisphosphonate partially protects periprosthetic bone, but does not enhance initial stability of uncemented femoral stems: a randomized placebo-controlled trial of women undergoing total hip arthroplasty","volume":"75","author":"Aro","year":"2018","journal-title":"J Biomech"},{"key":"10.1016\/j.arth.2025.04.049_bib7","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.arth.2017.02.036","article-title":"Efficacy of alendronate for the prevention of bone loss in calcar region following total hip arthroplasty","volume":"32","author":"Yukizawa","year":"2017","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.049_bib8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3109\/17453674.2015.1041846","article-title":"No effect of risedronate on femoral periprosthetic bone loss following total hip arthroplasty. A 4-year follow-up of 61 patients in a double-blind, randomized placebo-controlled trial","volume":"86","author":"Muren","year":"2015","journal-title":"Acta Orthop"},{"key":"10.1016\/j.arth.2025.04.049_bib9","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1530\/EOR-22-0121","article-title":"Bisphosphonates' use and risk of aseptic loosening following total hip arthroplasty: a systematic review","volume":"8","author":"Pegios","year":"2023","journal-title":"EFORT Open Rev"},{"key":"10.1016\/j.arth.2025.04.049_bib10","article-title":"Bisphosphonate use and risk of implant revision after total hip\/knee arthroplasty: a meta-analysis of observational studies","volume":"10","author":"Teng","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.arth.2025.04.049_bib11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.arth.2012.08.007","article-title":"Effect of zoledronic acid on reducing femoral bone mineral density loss following total hip arthroplasty: preliminary results of a prospective randomized trial","volume":"28","author":"Scott","year":"2013","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.049_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/145749691009900108","article-title":"Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty - a 5-year follow-up of 16 patients","volume":"99","author":"Tapaninen","year":"2010","journal-title":"Scand J Surg"},{"key":"10.1016\/j.arth.2025.04.049_bib13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2106\/JBJS.G.01193","article-title":"The effect of a single infusion of zoledronic acid on early implant migration in total hip arthroplasty. A randomized, double-blind, controlled trial","volume":"91","author":"Friedl","year":"2009","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.04.049_bib14","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1302\/0301-620X.88B10.17308","article-title":"Clinical and radiological outcome of total hip replacement five years after pamidronate therapy. A trial extension","volume":"88","author":"Shetty","year":"2006","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.arth.2025.04.049_bib15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00223-024-01192-6","article-title":"Postoperative bisphosphonates use is associated with reduced adverse outcomes after primary total joint arthroplasty of hip and knee: a nationwide population-based cohort study","volume":"114","author":"Shih","year":"2024","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.arth.2025.04.049_bib16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.arth.2023.08.029","article-title":"Bisphosphonate use may be associated with an increased risk of periprosthetic hip fracture","volume":"39","author":"Serino","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.049_bib17","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.arth.2023.11.036","article-title":"Initiation of bisphosphonates prior to total joint arthroplasty does not lower periprosthetic fracture risk","volume":"39","author":"Lee","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.049_bib18","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1177\/10711007231166926","article-title":"Does perioperative use of bisphosphonate affect the implant revision rate of total ankle arthroplasty?","volume":"44","author":"Lee","year":"2023","journal-title":"Foot Ankle Int"},{"key":"10.1016\/j.arth.2025.04.049_bib19","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/j.arth.2023.05.027","article-title":"The effect of preoperative bisphosphonate use on total hip arthroplasty outcomes","volume":"38","author":"Jeong","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.049_bib20","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1007\/s00167-018-5333-4","article-title":"The use of bisphosphonates after joint arthroplasty is associated with lower implant revision rate","volume":"27","author":"Ro","year":"2019","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"10.1016\/j.arth.2025.04.049_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1302\/0301-620X.101B2.BJJ-2018-0906.R1","article-title":"Preoperative bisphosphonate treatment may adversely affect the outcome after shoulder arthroplasty","volume":"101-B","author":"Mai","year":"2019","journal-title":"Bone Joint J"},{"key":"10.1016\/j.arth.2025.04.049_bib22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00264-016-3350-9","article-title":"What is the fate of the neck after a collum femoris preserving prosthesis? a nineteen years single center experience","volume":"41","author":"Formica","year":"2017","journal-title":"Int Orthop"},{"key":"10.1016\/j.arth.2025.04.049_bib23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.arth.2015.09.005","article-title":"Lower total knee arthroplasty revision risk associated with bisphosphonate use, even in patients with normal bone density","volume":"31","author":"Namba","year":"2016","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.049_bib24","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1007\/s11999-015-4263-4","article-title":"Association of bisphosphonate use and risk of revision after THA: outcomes from a US total joint replacement registry","volume":"473","author":"Khatod","year":"2015","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2025.04.049_bib25","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1002\/art.38789","article-title":"Oral bisphosphonate use and total knee\/hip implant survival: validation of results in an external population-based cohort","volume":"66","author":"Prieto-Alhambra","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.arth.2025.04.049_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d7222","article-title":"Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study","volume":"343","author":"Prieto-Alhambra","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.arth.2025.04.049_bib27","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.bone.2010.01.377","article-title":"Postoperative use of bisphosphonates and risk of revision after primary total hip arthroplasty: a nationwide population-based study","volume":"46","author":"Thillemann","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.arth.2025.04.049_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/21514593231182527","article-title":"Osteoporosis in the setting of shoulder arthroplasty: a narrative review","volume":"14","author":"Daher","year":"2023","journal-title":"Geriatr Orthop Surg Rehabil"},{"key":"10.1016\/j.arth.2025.04.049_bib29","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.arth.2022.10.042","article-title":"The association of postoperative osteoporosis therapy with periprosthetic fracture risk in patients undergoing arthroplasty for femoral neck fractures","volume":"38","author":"Cohen","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.049_bib30","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00198-023-06695-w","article-title":"Periprosthetic fractures: an unrecognized osteoporosis crisis","volume":"34","author":"Binkley","year":"2023","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.arth.2025.04.049_bib31","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11914-023-00793-8","article-title":"Advances in osteoporosis therapy: focus on osteoanabolic agents, secondary fracture prevention, and perioperative bone health","volume":"21","author":"Kostenuik","year":"2023","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.arth.2025.04.049_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5435\/00124635-200604000-00003","article-title":"Use of bisphosphonates to improve the durability of total joint replacements","volume":"14","author":"Shanbhag","year":"2006","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.arth.2025.04.049_bib33","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00198-024-07057-w","article-title":"Periprosthetic fractures are osteoporotic fractures: missed opportunities for osteoporosis diagnosis","volume":"35","author":"Whiting","year":"2024","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.arth.2025.04.049_bib34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jos.2024.01.011","article-title":"Anti-osteoporotic drug efficacy for periprosthetic bone loss after total hip arthroplasty: a systematic review and network meta-analysis","volume":"30","author":"Hatano","year":"2024","journal-title":"J Orthop Sci"},{"key":"10.1016\/j.arth.2025.04.049_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5371\/hp.2021.33.2.53","article-title":"Factors affecting periprosthetic bone loss after hip arthroplasty","volume":"33","author":"Lee","year":"2021","journal-title":"Hip Pelvis"},{"key":"10.1016\/j.arth.2025.04.049_bib36","doi-asserted-by":"crossref","DOI":"10.1177\/20420188221112904","article-title":"Timing of osteoporosis therapies following fracture: the current status","volume":"13","author":"Palui","year":"2022","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.arth.2025.04.049_bib37","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.arth.2019.03.044","article-title":"Osteoporosis is common and undertreated prior to total joint arthroplasty","volume":"34","author":"Bernatz","year":"2019","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.049_bib38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJMoa1916525","article-title":"Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates","volume":"383","author":"Black","year":"2020","journal-title":"N Engl J Med"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540325003845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540325003845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T10:05:07Z","timestamp":1758189907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540325003845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0883540325003845"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2025.04.049","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative Use of Bisphosphonate and Implant Survival After Total Joint Arthroplasty","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2025.04.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}